Artemis Medicare Services Ltd (AMSL) was incorporated on 2004, by the promoters of the Apollo Tyres Group, is engaged in healthcare business.
Artemis Medicare Services Ltd Q1FY24; 14% rise in Profits
Categories
Healthcare
Fortis Healthcare Ltd Q1FY24; 7% fall in Profits
FHL was incorporated in February 1996. The company’s first healthcare facility became operational in Mohali, Punjab in 2001. It is a leading
Amrutanjan Health Care Ltd Q1FY24; 92% rise in Profits.
AHCL has been manufacturing ayurvedic balm for pain management since 1893, and is currently managed by the third-generation of promoters. The company
SKM Egg Products Export (India) Ltd Q1FY24; 400% rise in Profits
SKM Egg Products Export (India) Ltd is engaged in the manufacture and sale of egg powder and liquid egg with varieties of
Thyrocare Technologies Ltd Q1FY24; 5% fall in Profits
Thyrocare Technologies is engaged in the business of healthcare industry and is involved in providing quality diagnostic services at affordable costs to
Dr Lal Pathlabs Ltd Q1FY24; 45% rise in Profits.
Dr. Lal PathLabs Limited is one of India’s leading consumer healthcare brand in diagnostic services. It has an integrated nationwide network, where
Alphagraph | Apollo Hospitals Enterprise Ltd (NSE: APOLLOHOSP): Q4FY23 Results Out; Total Income rises 21% YoY.
Apollo Hospitals, founded in 1983 by Dr. Prathap C Reddy, is a trailblazer in the Indian healthcare industry. It holds the distinction
Hester Biosciences Limited (HESTERBIO) Q4 FY23 Earnings Concall Transcript
Hester Biosciences Limited (NSE:HESTERBIO) Q4 FY23 Earnings Concall dated May. 17, 2023. Corporate Participants: Unidentified Speaker -- Analysts: Nirav Seksaria -- Living Root Capital --
Dr. Reddy’s Laboratories (DRREDDY) Q4 FY23 Earnings Concall Transcript
Dr. Reddy's Laboratories (NSE:DRREDDY) Q4 FY23 Earnings Concall dated May. 10, 2023. Corporate Participants: Richa Periwal -- Investor Relations G V Prasad -- Co-Chairman and Managing
Torrent Pharmaceuticals Ltd (TORNTPHARM) Q4 FY23 Earnings Concall Transcript
Torrent Pharmaceuticals Ltd (NSE: TORNTPHARM) Q4 FY23 Earnings Concall dated May. 30, 2023 Corporate Participants: Sudhir Menon — Executive Director, (Finance) and Chief Financial
Earnings Summary Of Global Health Limited For Q4 FY23
One of the largest private multi-specialty tertiary care organisations operating in India's North and East is Global Health Limited. Cardiology and cardiac
SUN PHARMACEUTICAL INDUSTRIES LIMITED (SUNPHARMA) Q4 FY23 Earnings Concall Transcript
SUN PHARMACEUTICAL INDUSTRIES LIMITED (NSE : SUNPHARMA) Q4 FY23 Earnings Concall dated May. 26, 2023. Corporate Participants: Abhishek Sharma -- Head of
Sequent Scientific Limited Q4 FY23 Earnings Conference Call Insights
Key highlights from Sequent Scientific Limited (SEQUENT) Q4 FY23 Earnings Concall Q&A Highlights: [00:14:02] Vishwas asked about the utilization of the API
Earnings Summary Of Fortis Healthcare Limited For Q4 FY23
Fortis Healthcare Limited is a leading integrated healthcare delivery service provider in India. With a strong network of hospitals and diagnostics centers,
Divi’s Laboratories Limited Q4 FY23; Net Profit Down By 64%
Divi's Laboratories Limited reported Total Income for Q4 FY23 of ₹2,016.92 Crore down from ₹2,570.83 Crore year on year, a decline of
Divi’s Laboratories Ltd (DIVISLAB) Q4 FY23 Earnings Concall Transcript
Divi's Laboratories Ltd (NSE: DIVISLAB) Q4 FY23 Earnings Concall dated May. 20, 2023 Corporate Participants: M. Satish Choudhury -- Company Secretary and Chief Investor
Zydus Lifesciences Ltd (ZYDUSLIFE) Q4 FY23 Earnings Concall Transcript
Zydus Lifesciences Ltd (NSE: ZYDUSLIFE) Q4 FY23 earnings concall dated May. 18, 2023 Corporate Participants: Ganesh Nayak -- Executive Director Sharvil Patel -- Managing Director Nitin
Shalby Ltd Q4FY23 results out, net profit grows by 40%
Shalby Ltd reported Total revenue for Q4 FY23 of ₹199 Crore, up from ₹163 Crore year on year depicting a growth of
Shalby Ltd Q4FY23 results out, revenue grows by 22%
Shalby Ltd is engaged in healthcare delivery space in India. It operates a chain of multi-specialty hospitals across India. The business of
Zydus Wellness Ltd (ZYDUSWELL) Q4 FY23 Earnings Concall Transcript
Zydus Wellness Ltd (NSE: ZYDUSWELL) Q4 FY23 earnings concall dated May. 17, 2023 Corporate Participants: Tarun Arora -- Chief Executive Officer and Whole Time
Max Healthcare Inst 4Q23; 85% Growth in Profit
Max Healthcare Institute’s revenue in Q4FY23 rose 26% to ₹ 1,637 crores. Consolidated Profit After Tax came at ₹ 320 crores in